Smoking is the practice of inhaling
or tasting of smoke released when a substance is burned. The most common
substance used for smoking is tobacco while the cannabis and opium are also
smoked often by people however less commonly. Most common smoking implement is
cigarettes followed by pipes, bidis, hookahs, cigars and vaporizers. Smoking is
considered as a serious threat to human health due to its risk associated with
medical conditions such as heart diseases, pulmonary diseases, respiratory
disorders, infertility, osteoporosis and cancer.
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/medicines-for-smoking-cessation-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018
The primary cause for smoking is the
gap between the lifestyles of different social classes. Curing of smoking
related diseases is possible and because of intense health related concerns,
primary health care providers are increasingly taking efforts for promoting
cessation of smoking in patients. Prior to the initiation of smoking cessation
therapy, important factors to be considered include patient’s willingness to
opt for therapy, its medical history, previous experience with anti-smoking
aids, and other patient characteristics such as contraindications, depression
history and level of smoking.
It is often recommended that
pharmacologic therapy should be combined with appropriate behavioral counseling
to the patient in order to enhance cessation rates in long term. Common
anti-smoking aids include prescription drugs, over-the-counter products, nicotine
replacement therapy, nicotine receptor partial agonist and antidepressant
therapy along with counseling, encouragement and support or referral to quit
smoking and programs for the same.
Drugs for smoking cessation are
categorized as first line agents, second line agents and combination therapy.
Several first line medications have been already approved by the FDA for
individuals attempting to quit smoking while there are several other therapies
which are recommended only if the patient is unable to quit smoking with
mono-therapy. Currently, the number of prescriptions for nicotine replacement
therapy and bupropion has been seen to reduce with a simultaneous increase in
the number of prescriptions for varenicline.
The major reason for growth in the
scope of this market is the increased number of smokers willing to curb smoking
habit. The market is predicted to grow continuously due to the rising incidence
and prevalence of smoking in developed and under-developed countries. Various
innovations and formulations in pipeline along with the availability of new
generic drugs and drug delivery technologies are also seen to be promising in
the near future.
Smoking remains the main segment in
list of cause for preventable diseases majorly in Americas followed by Europe.
Developing countries such as India, China, Brazil and Sweden also show growth
potential in the smoking cessation market. The demand for better anti-smoking
aids in market is attributed to the need for drugs with minimal side effects
and least scope for post-treatment relapse. The major market players for
anti-smoking aids are Johnson & Johnson Limited, GlaxoSmithKline
Pharmaceuticals Limited, Pfizer, Inc. and Novartis International AG.
This research report analyzes this market
depending on its market segments, major geographies, and current market trends.
Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints. It
provides market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model analysis and
detailed profiles of top industry players. The report also includes a review of
micro and macro factors essential for the existing market players and new
entrants along with detailed value chain analysis
About Us
MarketResearchReports.Biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment